A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
Clinical trial NCT06388564 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06388564
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-11
- Primary completion
- 2027-06-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.